The ability to activate the Nrf2 signaling pathway and to pass through the blood–brain barrier (BBB), in concert with other anti-inflammatory mechanisms, render the low concentrations of inhaled CO an emerging good candidate for neurologic protection after stroke. The gene discussed is NFE2L2; the disease is Stroke.